Huabei Pharmaceutical Group And DSM Agree On Joint Ventures
This article was originally published in PharmAsia News
Executive Summary
Huabei Pharmaceutical Group and DSM drafted 19 initial agreements for joint projects last November, including increasing the former's capital, joint ventures on nutrition products, assets transfer and technology permission. Although the final agreements have not been signed, the draft raises the likelihood of the collaboration to proceed. Huabei Pharmaceutical has identified seven priorities for 2009, and will quickly finalize the joint ventures and introduce funds, technology and management. Analysts observe that the firm will extend its raw Vitamin C materials to downstream formulation business as well as transfer DSM's "green enzyme techniques" to produce penicillin, while DSM is poised to get a slice of China's huge market from the partnership. (Click here for more - Chinese Language)